aureliabio.com Report : Visit Site

Technical data of the aureliabio.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host aureliabio.com. Currently, hosted in United Kingdom and its service provider is Heart Internet Ltd .

urlm.co.uk 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.4.33 (Unix) containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

bioassays & screening services- aurelia bioscience ltd 0115 837 0503 [email protected] facebook twitter google rss facebook twitter google rss services fee for service drug discovery projects what is involved example project instrument and reagent development capabilities high throughput screening cell-based screening phenotypic screening biochemical screening cell culture services specialised technologies label-free screening flipr screening fmat screening high content screening hypoxia and cancer quantitative pcr wes: western assay system 3-d cell biology publications & tech publications, articles & posters cool tech for your lab about us blog newsletters contact select page phenotypic screening we specialise in physiologically relevant assays using cell-based formats in state of the art technologies. we have used a number of human primary cells in a number of assay formats. find out more high content screening high content screening (hcs) uses microscopic imaging to observe, measure and analyse multiple parameters within cells in a biological assay. find out more label-free screening our scientists have in-depth experience of label-free technology applied to cell-based assays gained over the past 6 years using corning epic, perkinelmer enspire and sru bioscience bind instruments. find out more cell-based screening cell based assays are of key importance at a number of stages in the drug discovery process. being able to examine the interaction between your target and compounds in a cellular context is of great advantage. find out more cell culture services typical screens have required upwards of 10 10 cells. we have developed methodologies to grow, sub-culture, harvest, cryopreserve and revive these quantities of cells from single batches, thus reducing screening variability, allowing cells to be used in an identical manner to other assay reagents, reviving and using what is required on a daily basis. find out more download your free ebook to get exclusive insights into our expertise in assay design and development find out more bioassays & screening aurelia bioscience ltd is a pre-clinical contract research company focusing on supplying biochemical and cell-based compound screening expertise to small to medium enterprise (sme) companies, universities, research institutes, charities and large pharmaceuticals companies. our vision is to be recognised by our clients, partners and peers as a centre of excellence for these activities. underlying this is a desire to continue to contribute to the discovery of new therapeutic compounds for unmet medical need. capabilities high throughput screening with over 20 years of screening experience we are adept at designing and screening over 100,000 to 1 million compounds in 384 and 1536 well plates. cell culture services with over 30 years of experience we are adept at all aspects of cell culture. phenotypic screening we specialise in physiologically relevant assays using predominantly cell-based formats in state of the art technologies. bio chemical screening our team has extensive experience of developing and screening compounds in biochemical assays for a range of targets including but not limited to proteases, kinases, and phosphodiesterase enzymes and protein:protein interaction. cell-based screening cell based assays are of key importance at a number of stages in the drug discovery process. being able to examine the interaction between your target and compounds in a cellular context is of great advantage. label-free screening our scientists have in-depth experience of label-free technology applied to cell-based assays gained over the past 6 years using coring epic, perkin elmer enspire and sru bioscience bind instruments. flipr screening we have used flipr in a range of assay formats, readouts and target types. fmat screening the 8200 cellular detection system (fluorescent microvolume assay technology – fmat) from applied biosystems is a laser scanning macro-confocal fluorescent plate reader. high content screening we have used the ultra and micro hcs imaging devices in a range of assay formats involving different target types. news cardiomyocytes: building blocks of heart muscle jun 26, 2018 epigenetics: untangling the clues jun 20, 2018 actc conference 2018 may 25, 2018 8th kinase meeting may 18, 2018 new article published may 8, 2018 promega discover glo tour 2018 apr 25, 2018 our people scientists at aurelia have decades of experience between them working in real-world drug discovery projects utilising flipr, fmat, epic label free and envision-based assays in both biochemical and cell-based formats meet the management team services fee for service a comprehensive service to drug discovery clients including assay development, reagent testing and scale-up, proof of technology concept and validation, phenotypic screening and consultancy. drug discovery project the members of aurelia bioscience have been involved in the design and development of many drug discovery projects incorporating complex biology and implementing a suite of assays designed to identify “active” compounds and improve their biological properties. instrument & reagent development acting as an intermediary between instrument and reagent manufacturers and prospective clients we can provide an expert lab-based environment for the validation of new technologies. aurelia bioscience home services capabilities specialised technologies newsletters address aurelia bioscience ltd biocity nottingham pennyfoot street, nottingham ng1 1gf united kingdom contact 0115 837 0503 [email protected] facebook twitter google rss registered in england and wales. company number 7657187. vat number 116656510. copyright © 2018 aurelia bioscience ltd. all rights reserved. | designed by concept data terms | privacy

URL analysis for aureliabio.com

http://www.aureliabio.com/services/
http://www.aureliabio.com/capabilities/cell-culture-services/
http://www.aureliabio.com/specialised-technologies/flipr-screening/
http://www.aureliabio.com/services/fee-for-service/
http://www.aureliabio.com/specialised-technologies/wes/
http://www.aureliabio.com/capabilities/cell-based-screening/
http://www.aureliabio.com/services/drug-discovery-projects/
http://www.aureliabio.com/capabilities/biochemical-screening/
http://www.aureliabio.com/specialised-technologies/3-d-cell-biology/
http://www.aureliabio.com/specialised-technologies/quantitative-pcr/
http://www.aureliabio.com/publications-tech/tech/
http://www.aureliabio.com/contact/
http://www.aureliabio.com/specialised-technologies/fmat-screening/
http://www.aureliabio.com/specialised-technologies/high-content-screening/
http://www.aureliabio.com/capabilities/cell-based-screening/
conceptdata.co.uk

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: AURELIABIO.COM
Registry Domain ID: 1628878327_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.123-reg.co.uk
Registrar URL: http://www.meshdigital.com
Updated Date: 2016-12-02T10:12:19Z
Creation Date: 2010-12-05T19:45:08Z
Registry Expiry Date: 2018-12-05T19:45:08Z
Registrar: 123-Reg Limited
Registrar IANA ID: 1515
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: ok https://icann.org/epp#ok
Name Server: NS.MAINNAMESERVER.COM
Name Server: NS2.MAINNAMESERVER.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-10-20T07:58:45Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR 123-Reg Limited

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =aureliabio.com

  PORT 43

  TYPE domain

DOMAIN

  NAME aureliabio.com

  CHANGED 2016-12-02

  CREATED 2010-12-05

STATUS
ok https://icann.org/epp#ok

NSERVER

  NS.MAINNAMESERVER.COM 79.170.40.2

  NS2.MAINNAMESERVER.COM 79.170.43.3

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .